Navigation Links
EnVivo Pharmaceuticals Announces Executive Appointment
Date:9/26/2007

Dr. Dana C. Hilt Named SVP, Clinical Development & Chief Medical Officer

WATERTOWN, Mass., Sept. 26 /PRNewswire/ -- EnVivo Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs for neurodegenerative diseases, today announced the appointment of Dr. Dana C. Hilt as Senior Vice President and Chief Medical Officer. He will be responsible for coordinating all pre-clinical and clinical development activities of EnVivo's growing pipeline.

Dr. Hilt, 55, previously served as Senior Vice President, Clinical Research and Medical Affairs & Chief Medical Officer for Critical Therapeutics in Lexington, Massachusetts. Dr. Hilt is a distinguished neurologist with extensive drug development experience from his tenures at Amgen, Guilford Pharmaceuticals and Ascend Therapeutics. In addition, he has held both scientific and professorial positions with the University of Southern California School of Medicine, the National Institutes of Health and the University of Maryland School of Medicine where he was a clinical Associate Professor in the department of Neurology. At the beginning of his career, he was a Resident Fellow in Neurology at the Johns Hopkins University School of Medicine and interned at Harvard University Medical School.

Dr. Hilt is a member of the American Academy of Neurology, Movement Disorders Society, American Society for Experimental Neurotherapeutics, American Association for the Advancement of Science, Society for Neuroscience and Endocrine Society. He is the author of over 50 publications. Dr. Hilt received his Bachelor of Science Degree in Chemistry (with Distinction) from the University of Maine and an M.D. from the Tufts University School of Medicine.

"Given the continuing growth of EnVivo's pre-clinical and clinical programs in the field of neuro-degenerative diseases, Dana brings critically important skills to the management team. His deep expertise in drug development will be of increasing importance
'/>"/>

SOURCE EnVivo Pharmaceuticals, Inc.,
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Selexis SA, a serial innovation company ... (RCBs) used for drug discovery to commercial manufacturing, announced ... Next-Generation Sequencing (NGS) data packages. The NGS ... by ensuring the integrity of the gene, validation of ...
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision medicine ... to enable the broad use of genomic, imaging and other ... appointment of Michelle Munson , CEO of Aspera, an ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We ...
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
(Date:12/24/2014)... MA (PRWEB) December 23, 2014 ... is designed to introduce cutting edge communication technology, ... of platform upgrades. This webinar series demonstrates online ... quest to leverage web conferencing’s most innovative and ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3
... JERSEY CITY, N.J., Jan. 18, 2011 Intrasphere ... consulting and solutions firm that provides services to ... become a Gold level member of Oracle PartnerNetwork ... Argus Safety Suite. As a result of this ...
... , This release is available in German ... chemist Professor Ralph G. Nuzzo paved the way for use ... imaginable today without that innovation. Professor Nuzzo is now honored ... The award includes guest visits to the Institute of Functional ...
... Cancer Research Foundation ("KCRF") announces research conducted in the ... Cancer Center has been published in the December 2010 ... Clinical Cancer Research journal.  The manuscript illustrates how ... prove that radiofrequency fields can treat pancreatic tumors, which ...
Cached Biology Technology:Intrasphere Technologies Achieves Oracle PartnerNetwork Specialization for Oracle Argus Safety Suite 2Intrasphere Technologies Achieves Oracle PartnerNetwork Specialization for Oracle Argus Safety Suite 3New impulses for surface research 2Targeted Gold Nanoparticles and Noninvasive Radio Fields Attacking One of the Deadliest and Least Curable Types of Cancer: Pancreatic Carcinoma 2
(Date:1/22/2015)... 2015  Today, FreeWavz ( www.FreeWavz.com ), the developer ... on Fundable, https://www.fundable.com/freewavz . FreeWavz will be ... to meet customer demand. Logo - ... Invented by Dr. ...
(Date:1/22/2015)... 16, 2015  A man-made form of insulin delivered by ... capabilities in adults with mild cognitive impairment and Alzheimer,s ... researchers at Wake Forest Baptist Medical Center. ... mild cognitive impairment (MCI) or mild to moderate Alzheimer,s ...
(Date:1/22/2015)... , Jan. 21, 2015  Analyst Report Issued by Small ... Brands report showed that planet-wide, transactions at merchants on the ... the total number of credit, debit, and prepaid cards reached ... were victims of fraudulent card usage in 2012, and credit ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... NY, December 2, 2013--The Genetics Policy Institute (GPI) will bestow ... CEO of the company that bears her name, citing her ... community, and in raising the standard in medical research journalism. ... Mary Ann Liebert, Inc. , a media empire known ...
... that their children are affected. History provides examples ... children experience altered physiology. Now researchers at ... found an instance of animals passing on more ... offspring. That information comes not through social communication, ...
... CA---- A new approach to mapping how proteins interact ... Biological Studies, could aid in the design of new ... reengineering proteins using artificial amino acids, the Salk scientists ... and its ligand, the molecule that turns it on. ...
Cached Biology News:Mary Ann Liebert to receive award for stem cell education at World Stem Cell Summit in San Diego 2Mice can inherit learned sensitivity to a smell 2Mice can inherit learned sensitivity to a smell 3Salk scientists crack riddle of important drug target 2Salk scientists crack riddle of important drug target 3
... the value of your microarray data ... the support you need from consultation ... most up to date methods. Utilize ... Gene Expression Profiling Service or from ...
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap. (2/sp, 20/ca) Packaging: 2 / pack, 20 /...
... The pYD1 Yeast Display Vector is ... proteins on the surface of Saccharomyces cerevisiae. ... ability to interact with known or putative ... receptor which consists of two domains, Aga1 ...
... cells are used for heterologous protein expression in ... The S2 cell line was derived from a ... Drosophila melanogaster embryos (1). This ... without CO2 and is easily adapted to suspension ...
Biology Products: